Monitor for follow-on task orders or extensions under this PPV contract, which could increase the total value. The award is routine for McKesson's government business and does not materially change the company's revenue outlook.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 2 $924.78entry
- T+1 · 3mo ago −0.37%α −1.41% · $921.38
- T+5 · 2mo ago −4.75%α −3.79% · $880.86
- T+20 · 7w ago −2.81%α −2.65% · $898.82
- T+52 · todayOpen
- T+60 · in 10d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Department of Veterans Affairs awarded McKesson Corporation a new $1.47 billion pharmaceutical prime vendor contract. This is a large, single-agency award representing approximately 0.34% of McKesson's consensus annual revenue, supporting its government healthcare distribution business.
Key Financial Metrics
Published 61 days after the action
Key Facts
- Award amount: $1,465,753,427.88
- Awarding agency: Department of Veterans Affairs
- Contract type: New award (Pharmaceutical Prime Vendor for FY2026 September)
- Period of performance starts: 2026-09-01
- Award represents about 0.34% of McKesson's consensus annual revenue of $431.9 billion
Financial Impact
$1.47 billion contract, approximately 0.34% of consensus annual revenue
Risk Factors
- Government contracts are subject to funding availability and continuing resolutions
- Contract performance and renewal risks exist after the initial period
Investment Themes
Documents Analyzed
This report is based on 1 federal contract record from official U.S. government contract data.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-36C24026K1012 |
Track record
26 reports on MCK
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +22.92% at T+60 after the Apr 1, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Oct 30, 202617d ago 25-NSE Neutral 1/10 Entry $994.58 to $1,060.84 Now $1,102.81 +10.88% ▲ +6.66% +9.37% vs SPY
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,102.81 +14.81% ▲ +11.34% +12.05% vs SPY
- Oct 27, 202621d ago GOVT-CONTRACT Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,102.81 +14.81% ▲ +11.34% +12.05% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $955.76 to $1,010.43 Now $1,102.81 +15.39% ▲ +5.72% +7.21% vs SPY
- Oct 6, 20265w ago 8-K Bullish 6/10 Entry $921.67 to $961.88 Now $1,102.81 +19.65% ▲ +4.36% +4.50% vs SPY
- Sep 1, 202611w ago GOVT-CONTRACT Neutral 3/10 Viewing Entry $924.78 to $880.86 Now $1,102.81 +19.25% ▼ −4.75% −3.79% vs SPY
- Aug 28, 202611w ago 8-K Neutral 4/10 Entry $885.32 to $896.29 Now $1,102.81 +24.57% ▲ +1.24% +1.38% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers